Immunome Inc banner

Immunome Inc
NASDAQ:IMNM

Watchlist Manager
Immunome Inc Logo
Immunome Inc
NASDAQ:IMNM
Watchlist
Price: 24.63 USD 5.89% Market Closed
Market Cap: $2.8B

During the last 3 months Immunome Inc insiders bought 544.3k USD , and sold 2.9m USD worth of shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Apr 2, 2026 by Rosett Max , who sold 1.4m USD worth of IMNM shares.

Last Transactions:
Higgins Jack
$-204.2k
Rosett Max
$-1.4m
Siegall Clay B
$+500.6k
Wagenheim Philip
$-582.3k
Wagenheim Philip
Chief Financial Officer
$-753.3k
Bienaime Jean Jacques
$+21.6k
Bienaime Jean Jacques
Chief Financial Officer
$+22.1k
Siegall Clay B
$+100k
Barchas Isaac
$-8.1m
Siegall Clay B
$+149.1k
Tsai Philip
$+204.9k
Siegall Clay B
$+1 000k
Bienaime Jean Jacques
$+46.9k
Siegall Clay B
$+999.5k
Bienaime Jean Jacques
$+60.7k
Tsai Philip
$+103.6k
Bienaime Jean Jacques
$+57.5k
Siegall Clay B
$+1.2m
Siegall Clay B
$+331.9k
Lechleider Robert
$+149.8k
Tsai Philip
$+198k
Siegall Clay B
$+630.3k
Rosett Max
$-230.2k
Bienaime Jean Jacques
$+97.6k
Higgins Jack
$-49.1k
Siegall Clay B
$+281.5k
Bienaime Jean Jacques
$+27.1k
Siegall Clay B
$+1.1m
Turner Bruce
$+250k
Siegall Clay B
$+1 000k
Rapp Michael
$+518.2k
Rapp Michael
$+276.7k
View All Transactions

During the last 3 months Immunome Inc insiders bought 544.3k USD , and sold 2.9m USD worth of shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Apr 2, 2026 by Rosett Max , who sold 1.4m USD worth of IMNM shares.

Sold
0-3
months
2.9m USD
3
3-6
months
8.1m USD
1
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
2
544.3k USD
3-6
months
2
1.5m USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
1
46.9k USD

Immunome Inc
Insider Trading Chart

Immunome Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Immunome Inc
Last Insider Transactions

Global
Insiders Monitor

Immunome Inc
Glance View

Market Cap
2.8B USD
Industry
Biotechnology

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. The company is headquartered in Exton, Pennsylvania and currently employs 39 full-time employees. The company went IPO on 2020-10-02. The firm's primary focus areas are oncology and infectious diseases. Its discovery platform identifies therapeutic antibodies and their targets by leveraging components of the immune system, memory B cells, from patients who have learned to fight off their disease. Its lead discovery programs include IMM-ONC-01 and IMM-BCP-01. IMM-ONC-01, is its lead oncology program, which is focused on IL-38. IMM-BCP-01, is its lead infectious disease discovery program with a focus on SARS-CoV-2, the virus that causes COVID-19. The firm is developing an antibody cocktail product candidate by identifying a combination of anti-viral antibodies produced by B cells from COVID-19 super-responders.

IMNM Intrinsic Value
LOCKED
Unlock

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett